Commense Selects Merrimack Pharma Veteran Edward Stewart for CEO
Microbial therapies developer Commense has appointed Edward “Tad” Stewart to serve as the Boston company’s president and CEO. Stewart was most recently chief business officer of Cambridge, MA-ba...
Commense appoints president and CEO
Commense appoints new president and CEO
Commense Appoints Edward J. “Tad” Stewart as President and Chief Executive Officer
Industry veteran to lead next stage of growth for company Commense, Inc., an affiliate of PureTech Health plc (LSE:PRTC) developing microbiome-derived immune modulators for pe...
None
None
None
Commense, Inc., an affiliate of PureTech Health (LSE: PRTC), is developing interventions for pediatric and maternal health based on a deep understanding of the microbiome and its ...
We have published hundreds of Commense, Inc. news stories on BioPortfolio along with dozens of Commense, Inc. Clinical Trials and PubMed Articles about Commense, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commense, Inc. Companies in our database. You can also find out about relevant Commense, Inc. Drugs and Medications on this site too.